ClinicalTrials.gov
public full text
Public Domain
A Single Dose Trial of NNC 0155-0000-0004 in Patients With Haemophilia A
This trial is conducted in Asia and Europe. The aim of the trial is to investigate the pharmacokinetics (the rate at which the trial drug is eliminated from the body) of a single dose of turoctocog alfa (NNC 0155-0000-0004 (N8)) in patients with haemophilia A. Participation in this trial is dependent on previous participation in trial NN7008-3543 (Part B) (NCT00840086).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients#1164304
- Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A#899543
- Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects#1173293
- Combining Registry Data in Haemophilia: TARGET H#1045566
- Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial#1111957
Record · ID 829576
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive